PETV Stock Overview
A biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PetVivo Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.55 |
| 52 Week High | US$1.52 |
| 52 Week Low | US$0.29 |
| Beta | 2.53 |
| 11 Month Change | 1.70% |
| 3 Month Change | -9.12% |
| 1 Year Change | -57.04% |
| 33 Year Change | -87.42% |
| 5 Year Change | -77.00% |
| Change since IPO | -99.35% |
Recent News & Updates
Recent updates
Companies Like PetVivo Holdings (NASDAQ:PETV) Could Be Quite Risky
Nov 11
Will PetVivo Holdings (NASDAQ:PETV) Spend Its Cash Wisely?
Jul 26PetVivo Holdings GAAP EPS of -$0.57 beats by $0.37, revenue of $0.1M misses by $1.6M
Jun 29We Think PetVivo Holdings (NASDAQ:PETV) Can Afford To Drive Business Growth
Mar 23Shareholder Returns
| PETV | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 3.8% | 0.2% | -1.6% |
| 1Y | -57.0% | 25.8% | 30.8% |
Return vs Industry: PETV underperformed the US Medical Equipment industry which returned 25.5% over the past year.
Return vs Market: PETV underperformed the US Market which returned 30.6% over the past year.
Price Volatility
| PETV volatility | |
|---|---|
| PETV Average Weekly Movement | 17.0% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: PETV's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PETV's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 20 | John Lai | www.petvivo.com |
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company’s pipeline products also include therapeutic devices for veterinary and human clinical applications.
PetVivo Holdings, Inc. Fundamentals Summary
| PETV fundamental statistics | |
|---|---|
| Market cap | US$11.04m |
| Earnings (TTM) | -US$10.11m |
| Revenue (TTM) | US$975.27k |
11.3x
P/S Ratio-1.1x
P/E RatioIs PETV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PETV income statement (TTM) | |
|---|---|
| Revenue | US$975.27k |
| Cost of Revenue | US$229.87k |
| Gross Profit | US$745.40k |
| Other Expenses | US$10.85m |
| Earnings | -US$10.11m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 76.43% |
| Net Profit Margin | -1,036.51% |
| Debt/Equity Ratio | 2.3% |
How did PETV perform over the long term?
See historical performance and comparison